However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

The platform ‘Fertility Unfiltered’ encourages open conversations around fertility, highlighting real stories and practical ...

Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive ...

Mysuru: As part of World No Tobacco Day, Bharath Hospital and Institute of Oncology (BHIO), in association with Merck ...

Our Bureau, Mumbai Saturday, May 31, 2025, 15:30 Hrs [IST] ...

In a significant stride towards digital inclusion, the Government of India today launched four major Artificial Intelligence (AI) initiatives aimed at empowering persons with disabilities at a ...

Connected drug delivery devices integrate digital connectivity — often via Bluetooth — with traditional drug administration ...

EIK1003-001 (Abstract # CT197): A first-in-human, Phase 1/2 dose escalation, dose-optimization, and dose-expansion trial of PARP1-selective inhibitor EIK1003 in patients with advanced solid tumors.

Hosts are pulling their listings from sites like Airbnb, Vrbo, and Booking.com and transforming their properties into ...

Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.